(Q43574324)

24 November 2017

title

Kappa-opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes (English)

1 reference

24 November 2017

0 references

Peterson PK

1

1 reference

24 November 2017

Gekker G

2

1 reference

24 November 2017

Lokensgard JR

3

1 reference

24 November 2017

Bidlack JM

4

1 reference

24 November 2017

Chang AC

5

1 reference

24 November 2017

Fang X

6

1 reference

24 November 2017

Portoghese PS

7

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

24 November 2017

published in

Biochemical Pharmacology

1 reference

24 November 2017

volume

61

1 reference

24 November 2017

issue

9

1 reference

24 November 2017

page(s)

1145-1151

1 reference

The AIDS epidemic--considerations for the 21st century

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Perspectives of neuroimmune issues and substances of abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Aspartic acid conjugates of 2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1(3-aminophenyl)-2-(1-pyrrolidi nyl) ethyl]acetamide: kappa opioid receptor agonists with limited access to the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

TENA, a selective kappa opioid receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

G-protein-coupled receptor heterodimerization modulates receptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Opioid receptors on cells of the immune system: evidence for delta- and kappa-classes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Sequence of kappa-opioid receptor cDNA in the R1.1 thymoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Characterization of kappa-opioid receptor transcripts expressed by T cells and macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Identification of kappa opioid receptors in the immune system by indirect immunofluorescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Expression of kappa opioid receptors in human and monkey lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Inhibition of T cell superantigen responses following treatment with the kappa-opioid agonist U50,488H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Kappa-opioid regulation of thymocyte IL-7 receptor and C-C chemokine receptor 2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Opiate receptor-mediated chemotaxis of human monocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Dynorphin and related opioid peptides enhance tumoricidal activity mediated by murine peritoneal macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50,488H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

Kappa-opioid potentiation of tumor necrosis factor-alpha-induced anti-HIV-1 activity in acutely infected human brain cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900574-3

10.1016/S0006-2952(01)00574-3

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference